Breaking News, Collaborations & Alliances

Caprion Biosciences Acquires Primity Bio

Acquisition will further expand Caprion's immunology and molecular profiling service offerings

Caprion Biosciences has acquired Primity Bio Inc., a specialized provider of biomarker and immune monitoring services located in Fremont, California.  “The acquisition of Primity Bio provides us access to highly complementary and well-differentiated biomarker and immune monitoring services while considerably expanding our geographic reach to better support the global clinical needs of our clients,” said Martin Leblanc, president and chief executive officer of Caprion.  “Buil...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters